跳至主要内容
临床试验/TCTR20260726012
TCTR20260726012进行中(未招募)4 期

Hyaluronic acid filler for lip enhancement: a personalized approach based on Asian aesthetic preferences

Thanya Techapichetvanich0 个研究点目标入组 30 人开始时间: 2026年8月3日最近更新:
适应症

试验速览

阶段
4 期
状态
进行中(未招募)
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • aged 18-60 years
  • Patients with very thin to thin lips

排除标准

  • Participants with permanent facial implants below the subnasal region (e.g., polymethyl methacrylate [PMMA], silicone, or polytetrafluoroethylene [PTFE]).
  • Participants who have previously undergone autologous fat grafting or calcium hydroxyapatite (CaHA) injections below the subnasal region.
  • Participants who have received semi-permanent dermal fillers (e.g., poly-L-lactic acid [PLLA]) below the subnasal region within 6 months prior to enrolment, or temporary dermal fillers within 3 months prior to enrolment.
  • Participants who have received botulinum toxin injections within 6 months prior to enrolment or who plan to undergo botulinum toxin treatment during the study period.
  • Participants who have undergone skin resurfacing procedures, including laser therapy, radiofrequency, ultrasound-based treatments, or chemical peels, within 6 months prior to enrolment or who plan to undergo such procedures during the study period.
  • Participants who have received mesotherapy within 3 months prior to enrolment or who plan to undergo mesotherapy during the study period.
  • Participants with a history of hyaluronic acid dermal filler injection to the lips prior to enrolment.
  • Participants who have undergone thread lifting within 6 months prior to enrolment.
  • Participants who have undergone or are scheduled to undergo orthodontic treatment or dental procedures involving the oral region (e.g., tooth extraction) within 1 month prior to enrolment or during the study period.
  • Participants currently receiving anticoagulant therapy.
  • Participants who have taken non-steroidal anti-inflammatory drugs (NSAIDs), traditional herbal medicines, or other herbal products known to affect blood coagulation within 10 days prior to treatment.
  • Participants with active infection, inflammation, scars, or other lesions involving the lips or perioral region that may interfere with efficacy assessment.
  • Participants with a history of porphyria.
  • Participants with tattoos, piercings, or scars involving the lips or perioral region that may interfere with study assessments.
  • Participants with a known hypersensitivity or allergy to hyaluronic acid or its components.
  • Participants with a history of cardiac conduction abnormalities, hepatic disease, renal disease, or autoimmune disorders.
  • Participants who are pregnant, planning to become pregnant, or breastfeeding.

研究者

发起方
Thanya Techapichetvanich

相似试验